LA Times op-ed for one
"The Pfizer vaccine for those 12 and older is expected to receive full FDA approval this week, possibly Monday, which would allow doctors to prescribe it to children under 12 in what is called “off-label usage.” This could lead to yet another COVID-related health disparity, since the vaccination advantage is likely to go to the children of parents who have the time and money to seek out physicians offering such vaccinations.
Extensive off-label vaccination might not emerge if the FDA speeds up the authorization process of the vaccine for younger children. Parents who want to wait for more data could still do so — the safety evidence that will emerge from millions of children who would now be vaccinated."
|
(
In response to this post by BocaHoo91)
Link: LA Times
Posted: 08/23/2021 at 10:58AM